Aston University has issued a press release highlighting the work of Evolution Therapeutics and our mission to leverage the pro-resolving properties of extracellular vesicles for the treatment of non-healing wounds, such as diabetic foot ulcers, which impose a staggering £5.6 billion annual cost burden on the NHS.
To delve deeper into this exciting development, read the full article here: Aston University Press Release